BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3366183)

  • 1. [Changes in movement and ataxic gait with development in genetically ataxic mice: a comparison with the level of cerebellar cyclic nucleotide].
    Matsui K; Kato N; Ando K
    Jikken Dobutsu; 1988 Jan; 37(1):1-6. PubMed ID: 3366183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fundamental study on ataxic mice (wriggle mouse Sagami)].
    Matsui K; Mukoyama M; Adachi K; Ando K
    Jikken Dobutsu; 1987 Apr; 36(2):185-9. PubMed ID: 3038581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Automatic recording and analysis of the ambulatory dynamics of cerebellar ataxic mice-rolling mouse Nagoya, Reeler and Weaver (author's transl)].
    Toyoshima E; Maruhashi H; Matsui K; Mano Y; Ando K
    Jikken Dobutsu; 1981 Apr; 30(2):129-35. PubMed ID: 7286066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of somatostatin and cholecystokinin in the brain of ataxic mutant mice.
    Matsui K; Masui A; Kato N; Adachi K
    Life Sci; 1993; 53(4):333-40. PubMed ID: 8100981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the behavioral pharmacology of TRH-T in cytosine arabinoside-induced ataxic mice: a comparison with genetically ataxic mice].
    Matsui K; Mano Y; Mukoyama M; Muramoto O; Toyoshima E; Ando K
    Jikken Dobutsu; 1983 Jan; 32(1):13-9. PubMed ID: 6406242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of ataxia, spontaneous movement and the cerebellar noradrenaline system with aging in ataxic mice].
    Matsui K
    Jikken Dobutsu; 1986 Jan; 35(1):29-33. PubMed ID: 3709673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central noradrenaline metabolism in cerebellar ataxic mice.
    Muramoto O; Ando K; Kanazawa I
    Brain Res; 1982 Apr; 237(2):387-95. PubMed ID: 6123371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacological effect of thyrotropin-releasing hormone on ataxic mutant mice.
    Mano Y; Matsui K; Toyoshima E; Ando K
    Acta Neurol Scand; 1986 Apr; 73(4):352-8. PubMed ID: 3088901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of nerve growth factor level in the brain of genetically ataxic mice (weaver, reeler).
    Matsui K; Furukawa S; Shibasaki H; Kikuchi T
    FEBS Lett; 1990 Dec; 276(1-2):78-80. PubMed ID: 2265716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of thyrotropin releasing hormone on cerebellar mutant mice--a kinesiological comparison between rolling mouse Nagoya, weaver and reeler.
    Muroga T; Adachi K; Konagaya M; Takayanagi T; Sobue I
    Jpn J Med; 1982 Apr; 21(2):101-8. PubMed ID: 6811784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Elevated immunoreactive-somatostatin levels in the brain of ataxic mutant mice].
    Matsui K; Kato N; Watanabe N; Ando K
    Jikken Dobutsu; 1988 Jul; 37(3):263-8. PubMed ID: 2901364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin metabolism in the CNS in cerebellar ataxic mice.
    Ohsugi K; Adachi K; Ando K
    Experientia; 1986 Dec; 42(11-12):1245-7. PubMed ID: 2430828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrations of thyrotropin-releasing hormone in the brain of ataxic mice.
    Mitsuma T; Adachi K; Ando K
    J Neurol Sci; 1986 Sep; 75(2):135-9. PubMed ID: 3093641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotransmitter abnormality in Rolling mouse Nagoya, an ataxic mutant mouse.
    Muramoto O; Kanazawa I; Ando K
    Brain Res; 1981 Jun; 215(1-2):295-304. PubMed ID: 6167317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ataxia in rolling mouse Nagoya and the norepinephrine system--a psychopharmacological study].
    Matsui K; Toyoshima E; Mano U; Ando K
    Yakubutsu Seishin Kodo; 1982 Dec; 2(2):77-80. PubMed ID: 6821292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal expression of tyrosine hydroxylase not accompanied by phosphorylation at serine 40 in cerebellar Purkinje cells of ataxic mutant mice, rolling mouse Nagoya and dilute-lethal.
    Sawada K; Ando M; Sakata-Haga H; Sun XZ; Jeong YG; Hisano S; Takeda N; Fukui Y
    Congenit Anom (Kyoto); 2004 Mar; 44(1):46-50. PubMed ID: 15008900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-thyrotropin-releasing hormone concentrations in the brain of ataxic mice.
    Mitsuma T; Adachi K; Mukoyama M; Ando K
    J Neurol Sci; 1990 Sep; 98(2-3):163-7. PubMed ID: 2123001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vermectomy enhances parvalbumin expression and improves motor performance in weaver mutant mice: an animal model for cerebellar ataxia.
    Grüsser-Cornehls U; Grüsser C; Bäurle J
    Neuroscience; 1999; 91(1):315-26. PubMed ID: 10336081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of the behavioral phenotype in genetically ataxic mice through bilateral intracerebellar grafting of fetal Purkinje cells.
    Triarhou LC; Zhang W; Lee WH
    Cell Transplant; 1996; 5(2):269-77. PubMed ID: 8689037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared and specific signatures of locomotor ataxia in mutant mice.
    Machado AS; Marques HG; Duarte DF; Darmohray DM; Carey MR
    Elife; 2020 Jul; 9():. PubMed ID: 32718435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.